Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 33 (2-3) , 267-275
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology GroupJournal of Clinical Oncology, 2000
- Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer ProjectJournal of Clinical Oncology, 1999
- Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell linesBritish Journal of Cancer, 1999
- Scheduling of gemcitabine and cisplatin in Lewis Lung tumour bearing miceEuropean Journal of Cancer, 1999
- Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumorsAnnals of Oncology, 1999
- Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II studyAnnals of Oncology, 1999
- Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- The coordination chemistry of platinum anticancer drugs and related compounds with DNACoordination Chemistry Reviews, 1990